Skip to main content
IDDO Logo
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
    • Jobs
  • Data
    • Explore data
    • Accessing data
    • Data Access Guidelines
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
  • Science
    • Science
    • WWARN malaria
    • COVID-19
    • Ebola
    • Visceral leishmaniasis
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
    • Jobs
  • Data
    • Explore data
    • Accessing data
    • Data Access Guidelines
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
  • Science
    • Science
    • WWARN malaria
    • COVID-19
    • Ebola
    • Visceral leishmaniasis
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
LOGIN
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation

Resources for researchers

Downloadable resources for researchers 

Researcher in laboratory
i
Photo: Arne Hoel, World Bank

Collection of samples for amodiaquine / desethylamodiaquine pharmacology analysis

Procedure

 

 

Trial staff training

Procedure

 

 

Packaging and labeling investigational products/study drugs

Procedure

 

 

General evacuation of the clinical trial facility

Procedure

 

 

Follow-up visits

Procedure

 

 

Data recording by clinical trial staff

Procedure

 

 

Central receipt of investigational product

Procedure

 

 

Informed consent

Procedure

 

 

Pre- and post-admission team meetings

Procedure

 

 

Clinical conduct of scheduled admission periods

Procedure

 

 

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Current page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Next page ››
  • Last page Last »
Research Agenda Development Process
Research Agenda Development Process

View process

  • Navigation
    • About
  • Contact
    • info@iddo.org
  • Socials
    • LinkedIn
  • Newsletters
    • IDDO Newsletter
IDDO Footer logo
© 2025 Infectious Diseases Data Observatory
  • Cookies |
  • Privacy Notice |
  • Accessibility |
  • Sitemap |
  • Terms of use